Nano carriers for drug transport across the blood-brain barrier

被引:203
作者
Li, Xinming [1 ,2 ]
Tsibouklis, John [2 ]
Weng, Tingting [3 ]
Zhang, Buning
Yin, Guoqiang [1 ]
Feng, Guangzhu [1 ]
Cui, Yingde [1 ]
Savina, Irina N. [4 ]
Mikhalovska, Lyuba I. [4 ]
Sandeman, Susan R. [4 ]
Howel, Carol A. [4 ]
Mikhalovsky, Sergey V. [4 ,5 ]
机构
[1] Zhongkai Univ Agr & Engn, Sch Chem & Chem Engn, 24 Dongsha St, Guangzhou 510225, Guangdong, Peoples R China
[2] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England
[3] Guangdong Petr & Chem Technol Inst, Dept Chem Engn, Foshan, Peoples R China
[4] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England
[5] Nazarbayev Univ, Sch Engn, Astana, Kazakhstan
关键词
Blood-brain barrier; drug delivery; nanomaterials; SOLID LIPID NANOPARTICLES; PLASMA-PROTEIN ADSORPTION; IN-VITRO ASSESSMENT; TARGETED DELIVERY; POLYMERIC NANOPARTICLES; CNS DELIVERY; ANTICANCER DRUGS; QUANTUM DOTS; MAGNETIC NANOPARTICLES; COLLOIDAL CARRIERS;
D O I
10.1080/1061186X.2016.1184272
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effective therapy lies in achieving a therapeutic amount of drug to the proper site in the body and then maintaining the desired drug concentration for a sufficient time interval to be clinically effective for treatment. The blood-brain barrier (BBB) hinders most drugs from entering the central nervous system (CNS) from the blood stream, leading to the difficulty of delivering drugs to the brain via the circulatory system for the treatment, diagnosis and prevention of brain diseases. Several brain drug delivery approaches have been developed, such as intracerebral and intracerebroventricular administration, intranasal delivery and blood-to-brain delivery, as a result of transient BBB disruption induced by biological, chemical or physical stimuli such as zonula occludens toxin, mannitol, magnetic heating and ultrasound, but these approaches showed disadvantages of being dangerous, high cost and unsuitability for most brain diseases and drugs. The strategy of vector-mediated blood-to-brain delivery, which involves improving BBB permeability of the drug-carrier conjugate, can minimize side effects, such as being submicrometre objects that behave as a whole unit in terms of their transport and properties, nanomaterials, are promising carrier vehicles for direct drug transport across the intact BBB as a result of their potential to enter the brain capillary endothelial cells by means of normal endocytosis and transcytosis due to their small size, as well as their possibility of being functionalized with multiple copies of the drug molecule of interest. This review provids a concise discussion of nano carriers for drug transport across the intact BBB, various forms of nanomaterials including inorganic/solid lipid/polymeric nanoparticles, nanoemulsions, quantum dots, nanogels, liposomes, micelles, dendrimers, polymersomes and exosomes are critically evaluated, their mechanisms for drug transport across the BBB are reviewed, and the future directions of this area are fully discussed.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [41] Characteristics of substance P transport across the blood-brain barrier
    Chappa, Arvind K.
    Audus, Kenneth L.
    Lunte, Susan M.
    PHARMACEUTICAL RESEARCH, 2006, 23 (06) : 1201 - 1208
  • [42] The blood-brain barrier: Physiology and strategies for drug delivery
    Pandit, Rucha
    Chen, Liyu
    Gotz, Jurgen
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 165-166 (165-166) : 1 - 14
  • [43] Stroke upregulates TNFα transport across the blood-brain barrier
    Pan, WH
    Ding, YM
    Yu, YM
    Ohtaki, H
    Nakamachi, T
    Kastin, AJ
    EXPERIMENTAL NEUROLOGY, 2006, 198 (01) : 222 - 233
  • [44] Effect of bioflavonoids on vincristine transport across blood-brain barrier
    Mitsunaga, Y
    Takanaga, H
    Matsuo, H
    Naito, M
    Tsuruo, T
    Ohtani, H
    Sawada, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 395 (03) : 193 - 201
  • [45] Nanoscale drug delivery systems and the blood-brain barrier
    Alyautdin, Renad
    Khalin, Igor
    Nafeeza, Mohd Ismail
    Haron, Muhammad Huzaimi
    Kuznetsov, Dmitry
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 795 - 811
  • [46] Effects of apolipoproteins on dalargin transport across the blood-brain barrier
    D. A. Shamenkov
    V. E. Petrov
    R. N. Alyautdin
    Bulletin of Experimental Biology and Medicine, 2006, 142 : 703 - 706
  • [47] Investigation of substance P transport across the blood-brain barrier
    Freed, AL
    Audus, KL
    Lunte, SM
    PEPTIDES, 2002, 23 (01) : 157 - 165
  • [48] Regulatory mechanisms for iron transport across the blood-brain barrier
    Duck, Kari A.
    Simpson, Ian A.
    Connor, James R.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 494 (1-2) : 70 - 75
  • [49] Effects of apolipoproteins on dalargin transport across the blood-brain barrier
    Shamenkov, D. A.
    Petrov, V. E.
    Alyautdin, R. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 142 (06) : 703 - 706
  • [50] The physics of drug-delivery across the blood-brain barrier
    Guiot, C.
    Zullino, S.
    Priano, L.
    Cavalli, R.
    THERAPEUTIC DELIVERY, 2016, 7 (03) : 153 - 156